WINDLAS BIOTECH
Back to Income Statement
|
WINDLAS BIOTECH Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹760 Cr | ₹631 Cr | ₹513 Cr | ₹466 Cr | ₹428 Cr |
What is the latest Revenue of WINDLAS BIOTECH ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹760 Cr |
| Mar2024 | ₹631 Cr |
| Mar2023 | ₹513 Cr |
| Mar2022 | ₹466 Cr |
| Mar2021 | ₹428 Cr |
How is Revenue of WINDLAS BIOTECH Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹760 Cr | 20.43 | |
| Mar2024 | ₹631 Cr | 22.97 | |
| Mar2023 | ₹513 Cr | 10.12 | |
| Mar2022 | ₹466 Cr | 8.96 | |
| Mar2021 | ₹428 Cr | - | |
Compare Revenue of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,674.4 Cr | -4.2% | -16.7% | -18.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,034.0 Cr | 0.9% | 5.3% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,211.0 Cr | -2.3% | -3.3% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹124,875.0 Cr | -3.3% | 2.8% | 19.7% | Stock Analytics | |
| CIPLA | ₹122,082.0 Cr | -1.6% | -9.2% | 4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,873.0 Cr | NA | -3.5% | 4.6% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -4.2% |
-16.7% |
-18.2% |
| SENSEX | 0.8% |
1% |
9.9% |
You may also like the below Video Courses